What causes high direct bilirubin?

High direct bilirubin typically indicates liver dysfunction or bile duct obstruction, with causes ranging from hepatitis and cirrhosis to gallstones and medications. Testing your liver function biomarkers can help identify the underlying cause and guide appropriate treatment.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Direct Bilirubin and Its Role in Your Body

Direct bilirubin, also known as conjugated bilirubin, is a water-soluble form of bilirubin that your liver produces as part of the normal breakdown of red blood cells. When old red blood cells are broken down, they release hemoglobin, which is converted to unconjugated (indirect) bilirubin. Your liver then processes this indirect bilirubin by adding glucuronic acid, creating direct bilirubin that can be easily excreted through bile into your intestines.

Normal direct bilirubin levels typically range from 0.0 to 0.3 mg/dL, representing about 20% of your total bilirubin. When these levels rise above normal, it often signals a problem with your liver's ability to process and excrete bilirubin, or an obstruction preventing bile from flowing properly. Understanding what causes elevated direct bilirubin is crucial for identifying potential health issues early and taking appropriate action.

Primary Causes of Elevated Direct Bilirubin

Liver Disease and Dysfunction

The most common cause of high direct bilirubin is liver disease. When liver cells are damaged or inflamed, they struggle to process and excrete bilirubin efficiently. Hepatitis, whether viral (hepatitis A, B, or C), alcoholic, or autoimmune, causes inflammation that impairs the liver's ability to conjugate and excrete bilirubin. Cirrhosis, the advanced scarring of liver tissue, similarly disrupts normal liver function and bile flow.

Common Medications That Can Elevate Direct Bilirubin

This table shows common medications associated with elevated direct bilirubin. Always consult your healthcare provider before stopping any prescribed medication.
Medication ClassExamplesMechanismTypical Onset
AntibioticsAntibioticsAmoxicillin-clavulanate, Erythromycin, NitrofurantoinDirect hepatotoxicity or cholestasisDays to weeks
StatinsStatinsAtorvastatin, SimvastatinHepatocellular injuryWeeks to months
AntifungalsAntifungalsKetoconazole, FluconazoleInhibition of bile acid transportDays to weeks
NSAIDsNSAIDsDiclofenac, Ibuprofen (high doses)Mixed hepatocellular-cholestatic injuryWeeks to months
Herbal SupplementsHerbal SupplementsKava, Green tea extract, Garcinia cambogiaVarious mechanismsWeeks to months

This table shows common medications associated with elevated direct bilirubin. Always consult your healthcare provider before stopping any prescribed medication.

Non-alcoholic fatty liver disease (NAFLD), affecting up to 25% of adults globally, can also elevate direct bilirubin levels as fat accumulation interferes with liver function. Primary biliary cholangitis and primary sclerosing cholangitis, autoimmune conditions affecting the bile ducts within the liver, cause progressive damage that leads to elevated direct bilirubin levels. If you're concerned about your liver health, comprehensive testing can provide valuable insights into your liver function biomarkers.

Bile Duct Obstruction

Blockages in the bile ducts prevent direct bilirubin from being excreted normally, causing it to back up into the bloodstream. Gallstones are the most frequent culprit, particularly when they migrate from the gallbladder into the common bile duct. These stones can completely or partially block bile flow, leading to rapid increases in direct bilirubin levels.

Tumors affecting the pancreas, bile ducts, or surrounding structures can compress or invade the bile ducts, causing obstruction. Pancreatic cancer, cholangiocarcinoma (bile duct cancer), and ampullary tumors are serious conditions that often present with elevated direct bilirubin as an early sign. Strictures or narrowing of the bile ducts from previous surgery, inflammation, or injury can also impede bile flow.

Genetic and Metabolic Disorders

Several inherited conditions can cause elevated direct bilirubin levels. Dubin-Johnson syndrome and Rotor syndrome are rare genetic disorders that impair the liver's ability to excrete conjugated bilirubin into bile. While these conditions are generally benign, they cause chronic elevation of direct bilirubin levels and may result in mild jaundice.

Wilson's disease, a genetic disorder causing copper accumulation in the liver and other organs, can lead to liver damage and elevated direct bilirubin. Hemochromatosis, characterized by excessive iron absorption and storage, similarly damages liver tissue over time, potentially raising direct bilirubin levels.

Medications and Toxins That Raise Direct Bilirubin

Numerous medications can cause drug-induced liver injury, leading to elevated direct bilirubin levels. Understanding these potential causes is essential for proper diagnosis and treatment.

Antibiotics like amoxicillin-clavulanate, erythromycin, and certain fluoroquinolones are common culprits. Statins, while generally safe, can occasionally cause liver enzyme elevations and increased bilirubin in sensitive individuals. Acetaminophen overdose is a well-known cause of acute liver failure and dramatically elevated bilirubin levels.

Other medications associated with elevated direct bilirubin include certain antifungals, anti-seizure medications, anabolic steroids, and some herbal supplements. Always inform your healthcare provider about all medications and supplements you're taking, as drug-induced liver injury can develop weeks to months after starting a new medication.

Recognizing Symptoms of High Direct Bilirubin

Elevated direct bilirubin often presents with characteristic symptoms that warrant medical attention. Jaundice, the yellowing of skin and eyes, typically becomes visible when total bilirubin exceeds 2.5-3.0 mg/dL. Dark urine, often described as tea or cola-colored, occurs because water-soluble direct bilirubin is excreted through the kidneys when it cannot flow normally through bile.

Additional symptoms may include:

  • Pale or clay-colored stools (due to lack of bilirubin reaching the intestines)
  • Intense itching (pruritus) without rash
  • Abdominal pain, particularly in the right upper quadrant
  • Nausea and vomiting
  • Fatigue and weakness
  • Loss of appetite and unintentional weight loss
  • Fever (if infection is present)

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Diagnostic Tests and Evaluation

Proper evaluation of elevated direct bilirubin requires a comprehensive approach. Initial blood tests typically include a complete metabolic panel with liver function tests, measuring not only direct and total bilirubin but also enzymes like ALT, AST, and alkaline phosphatase. These markers help distinguish between hepatocellular injury (liver cell damage) and cholestatic patterns (bile flow obstruction).

Additional testing may include:

  • GGT (gamma-glutamyl transferase) to confirm bile duct involvement
  • Prothrombin time/INR to assess liver synthetic function
  • Viral hepatitis serologies
  • Autoimmune markers (ANA, anti-smooth muscle antibodies)
  • Imaging studies (ultrasound, CT, or MRI) to visualize liver and bile ducts
  • ERCP or MRCP for detailed bile duct evaluation
  • Liver biopsy in select cases

Regular monitoring of liver function biomarkers can help detect problems early, before symptoms develop. This is particularly important for individuals with risk factors like obesity, diabetes, heavy alcohol use, or family history of liver disease.

Treatment Approaches Based on Underlying Cause

Treatment for elevated direct bilirubin depends entirely on addressing the underlying cause. For bile duct obstructions from gallstones, endoscopic removal or surgery may be necessary. Tumors causing obstruction might require surgical resection, chemotherapy, or palliative stenting to restore bile flow.

Liver disease management varies by cause. Viral hepatitis may require antiviral medications, while autoimmune hepatitis responds to immunosuppressive therapy. Alcoholic liver disease necessitates complete alcohol cessation and nutritional support. NAFLD management focuses on weight loss, dietary changes, and treating associated metabolic conditions like diabetes and high cholesterol.

Drug-induced liver injury typically improves with discontinuation of the offending medication, though severe cases may require hospitalization and supportive care. Genetic conditions like Dubin-Johnson syndrome usually require no specific treatment beyond monitoring and avoiding medications that could worsen liver function.

Prevention and Long-term Management Strategies

Preventing elevated direct bilirubin involves maintaining optimal liver health through lifestyle choices. Limit alcohol consumption to recommended levels (no more than one drink daily for women, two for men), maintain a healthy weight through balanced nutrition and regular exercise, and avoid unnecessary medications and supplements that could stress your liver.

Key prevention strategies include:

  • Get vaccinated against hepatitis A and B
  • Practice safe behaviors to prevent hepatitis C transmission
  • Manage chronic conditions like diabetes and high cholesterol
  • Avoid sharing needles or personal items that could transmit bloodborne viruses
  • Use acetaminophen and other potentially hepatotoxic drugs cautiously
  • Stay hydrated and eat a diet rich in fruits, vegetables, and whole grains
  • Exercise regularly to maintain healthy body weight and improve liver function

When High Direct Bilirubin Requires Immediate Medical Attention

While mild elevations in direct bilirubin may not cause immediate symptoms, certain situations require urgent medical evaluation. Seek immediate care if you experience sudden onset of jaundice, severe abdominal pain, high fever with jaundice, confusion or altered mental status, or persistent vomiting preventing fluid intake.

These symptoms could indicate acute liver failure, ascending cholangitis (bile duct infection), or complete bile duct obstruction requiring emergency intervention. Early recognition and treatment of these conditions can be life-saving and prevent permanent liver damage.

The Importance of Regular Monitoring

For individuals with known liver disease or risk factors, regular monitoring of direct bilirubin and other liver function markers is essential. This allows for early detection of disease progression and timely adjustment of treatment strategies. Even those without known liver disease benefit from periodic screening, as many liver conditions remain asymptomatic until advanced stages.

Understanding your baseline liver function values and tracking changes over time provides valuable insight into your liver health. This proactive approach enables you to work with your healthcare provider to address potential issues before they become serious, ultimately protecting your long-term health and well-being.

References

  1. Fevery, J. (2008). Bilirubin in clinical practice: a review. Liver International, 28(5), 592-605.[Link][PubMed][DOI]
  2. Vítek, L., & Ostrow, J. D. (2009). Bilirubin chemistry and metabolism; harmful and protective aspects. Current Pharmaceutical Design, 15(25), 2869-2883.[PubMed]
  3. European Association for the Study of the Liver. (2019). EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology, 70(6), 1222-1261.[Link][DOI]
  4. Erlinger, S., Arias, I. M., & Dhumeaux, D. (2014). Inherited disorders of bilirubin transport and conjugation: new insights into molecular mechanisms and consequences. Gastroenterology, 146(7), 1625-1638.[PubMed][DOI]
  5. Sticova, E., & Jirsa, M. (2013). New insights in bilirubin metabolism and their clinical implications. World Journal of Gastroenterology, 19(38), 6398-6407.[PubMed][DOI]
  6. Kuntz, E., & Kuntz, H. D. (2008). Hepatology: Textbook and Atlas (3rd ed.). Springer-Verlag Berlin Heidelberg.[DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my direct bilirubin at home?

You can test your direct bilirubin at home with SiPhox Health's Heart & Metabolic Program, which includes direct bilirubin testing along with other essential liver function markers. This CLIA-certified program provides lab-quality results from the comfort of your home.

What is the normal range for direct bilirubin?

Normal direct bilirubin levels typically range from 0.0 to 0.3 mg/dL in adults. Values above this range may indicate liver dysfunction or bile duct obstruction and should be evaluated by a healthcare provider.

Can high direct bilirubin levels return to normal?

Yes, direct bilirubin levels often normalize once the underlying cause is treated. For example, removing gallstones, treating hepatitis, or stopping hepatotoxic medications can restore normal bilirubin levels. The timeline depends on the specific cause and severity of liver involvement.

What's the difference between direct and indirect bilirubin?

Indirect bilirubin is the unconjugated form produced from red blood cell breakdown, while direct bilirubin is conjugated by the liver for excretion. High indirect bilirubin suggests increased red blood cell destruction or liver processing issues, while high direct bilirubin indicates problems with bile excretion or liver cell function.

Should I avoid certain foods if I have high direct bilirubin?

While no specific foods directly lower bilirubin, maintaining a liver-friendly diet helps overall liver function. Limit alcohol, reduce saturated fats and processed foods, and increase intake of fruits, vegetables, and whole grains. Stay hydrated and avoid supplements that could stress your liver without consulting your healthcare provider.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details